Stonepine Capital Management as of Sept. 30, 2017
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 22 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Viveve Med | 11.9 | $20M | 3.8M | 5.24 | |
| Enanta Pharmaceuticals (ENTA) | 10.8 | $18M | 390k | 46.80 | |
| Pacira Pharmaceuticals (PCRX) | 8.3 | $14M | 375k | 37.55 | |
| Recro Pharma | 7.7 | $13M | 1.5M | 8.98 | |
| Noveliontherapeuti.. | 7.6 | $13M | 1.8M | 7.03 | |
| BioDelivery Sciences International | 6.7 | $11M | 3.9M | 2.95 | |
| Apollo Endosurgery | 6.5 | $11M | 2.4M | 4.68 | |
| Flamel Technologies Sa | 6.1 | $10M | 985k | 10.50 | |
| BioSpecifics Technologies | 5.8 | $9.8M | 211k | 46.52 | |
| Ophthotech | 5.8 | $9.8M | 3.5M | 2.82 | |
| Cumberland Pharmaceuticals (CPIX) | 5.3 | $9.0M | 1.3M | 7.06 | |
| Cardiome Pharma | 3.6 | $6.1M | 2.9M | 2.13 | |
| Vericel (VCEL) | 3.5 | $5.9M | 976k | 6.00 | |
| Vanda Pharmaceuticals (VNDA) | 3.2 | $5.4M | 300k | 17.90 | |
| Cti Biopharma | 1.9 | $3.2M | 993k | 3.19 | |
| Veracyte (VCYT) | 1.7 | $2.9M | 330k | 8.77 | |
| Oxford Immunotec Global | 1.6 | $2.7M | 162k | 16.80 | |
| Intercept Pharmaceuticals In | 0.6 | $1.1M | 19k | 58.06 | |
| CAS Medical Systems | 0.4 | $748k | 813k | 0.92 | |
| Trinity Biotech | 0.4 | $688k | 123k | 5.61 | |
| Alimera Sciences | 0.4 | $644k | 477k | 1.35 | |
| Combimatrix Corporation | 0.3 | $475k | 63k | 7.51 |
